Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity.

Hamid MHBA. et al, (2024), Nat Immunol

Oncogenic cell tagging and single-cell transcriptomics reveal cell type-specific and time-resolved responses to Vhl inactivation in the kidney.

Kurlekar S. et al, (2024), Cancer Res

Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell culture

Lv X. et al, (2024), iScience, 27

Deficiency of factor-inhibiting HIF creates a tumor-promoting immune microenvironment.

Ma J. et al, (2024), Proc Natl Acad Sci U S A, 121

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.

Datoo MS. et al, (2024), Lancet, 403, 533 - 544

The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study.

Schmit N. et al, (2024), Lancet Infect Dis

Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study

Elneima O. et al, (2024), International Journal of Epidemiology, 53

Apoptosis-mediated ADAM10 activation removes a mucin barrier promoting T cell efferocytosis.

Drexhage LZ. et al, (2024), Nat Commun, 15

A common NFKB1 variant detected through antibody analysis in UK Biobank predicts risk of infection and allergy.

Chong AY. et al, (2024), Am J Hum Genet

Accelarated immune ageing is associated with COVID-19 disease severity.

Lord JM. et al, (2024), Immun Ageing, 21

A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM).

Dayimu A. et al, (2024), Eur J Cancer, 196

The British Society for Gene and Cell Therapy at 20 (2003–2023)

Seymour L. et al, (2024), Human Gene Therapy, 35, 5 - 8

Using CombiCells, a platform for titration and combinatorial display of cell surface ligands, to study T-cell antigen sensitivity modulation by accessory receptors.

Patel A. et al, (2024), EMBO J, 43, 132 - 150

Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents.

Ratcliffe H. et al, (2023), iScience, 26

N1-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting.

Mulroney TE. et al, (2023), Nature

Durability and cross-reactive immune memory to SARS-CoV-2 in individuals 2 years after recovery from COVID-19: a longitudinal cohort study.

Guo L. et al, (2023), Lancet Microbe

Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera

Roper KJ. et al, (2023), Scientific Reports, 13

Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases.

Pagnamenta AT. et al, (2023), Genome Med, 15

Geography Influences Susceptibility to SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease: Multinational Analysis From the ICARUS-IBD Consortium.

Wong S-Y. et al, (2023), Inflamm Bowel Dis, 29, 1693 - 1705

Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors.

Gu X. et al, (2023), EBioMedicine, 98

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?